nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP1A1—lung cancer	0.244	1	CbGaD
Pentamidine—CYP4A11—Cisplatin—lung cancer	0.0907	0.194	CbGbCtD
Pentamidine—CYP1A1—Gefitinib—lung cancer	0.038	0.0814	CbGbCtD
Pentamidine—CYP3A5—Gefitinib—lung cancer	0.0228	0.0488	CbGbCtD
Pentamidine—CYP1A1—Erlotinib—lung cancer	0.0225	0.0481	CbGbCtD
Pentamidine—CYP3A5—Teniposide—lung cancer	0.0221	0.0474	CbGbCtD
Pentamidine—CYP2C19—Gefitinib—lung cancer	0.0184	0.0394	CbGbCtD
Pentamidine—CYP2C19—Teniposide—lung cancer	0.0178	0.0382	CbGbCtD
Pentamidine—CYP2D6—Gefitinib—lung cancer	0.014	0.03	CbGbCtD
Pentamidine—CYP3A5—Crizotinib—lung cancer	0.014	0.0299	CbGbCtD
Pentamidine—CYP3A5—Erlotinib—lung cancer	0.0135	0.0289	CbGbCtD
Pentamidine—CYP2C8—Erlotinib—lung cancer	0.013	0.0278	CbGbCtD
Pentamidine—CYP3A5—Paclitaxel—lung cancer	0.0123	0.0264	CbGbCtD
Pentamidine—CYP3A5—Irinotecan—lung cancer	0.0122	0.0261	CbGbCtD
Pentamidine—CYP2C8—Paclitaxel—lung cancer	0.0119	0.0254	CbGbCtD
Pentamidine—CYP2D6—Vinorelbine—lung cancer	0.0108	0.0231	CbGbCtD
Pentamidine—CYP1A2—Erlotinib—lung cancer	0.01	0.0215	CbGbCtD
Pentamidine—CYP3A5—Etoposide—lung cancer	0.00975	0.0209	CbGbCtD
Pentamidine—CYP3A4—Topotecan—lung cancer	0.00972	0.0208	CbGbCtD
Pentamidine—CYP2C8—Etoposide—lung cancer	0.00937	0.0201	CbGbCtD
Pentamidine—CYP3A5—Docetaxel—lung cancer	0.00892	0.0191	CbGbCtD
Pentamidine—CYP3A4—Gefitinib—lung cancer	0.00889	0.019	CbGbCtD
Pentamidine—CYP3A4—Teniposide—lung cancer	0.00862	0.0185	CbGbCtD
Pentamidine—CYP2D6—Erlotinib—lung cancer	0.00826	0.0177	CbGbCtD
Pentamidine—CYP1A2—Etoposide—lung cancer	0.00726	0.0155	CbGbCtD
Pentamidine—CYP3A4—Vinorelbine—lung cancer	0.00685	0.0147	CbGbCtD
Pentamidine—CYP2D6—Vinblastine—lung cancer	0.00664	0.0142	CbGbCtD
Pentamidine—CYP3A4—Crizotinib—lung cancer	0.00545	0.0117	CbGbCtD
Pentamidine—CYP3A4—Erlotinib—lung cancer	0.00525	0.0113	CbGbCtD
Pentamidine—CYP3A4—Paclitaxel—lung cancer	0.00481	0.0103	CbGbCtD
Pentamidine—CYP3A4—Irinotecan—lung cancer	0.00475	0.0102	CbGbCtD
Pentamidine—CYP3A4—Vinblastine—lung cancer	0.00422	0.00904	CbGbCtD
Pentamidine—CYP2D6—Doxorubicin—lung cancer	0.00408	0.00874	CbGbCtD
Pentamidine—CYP3A4—Etoposide—lung cancer	0.0038	0.00815	CbGbCtD
Pentamidine—CYP3A4—Docetaxel—lung cancer	0.00348	0.00745	CbGbCtD
Pentamidine—CYP3A4—Doxorubicin—lung cancer	0.00259	0.00556	CbGbCtD
Pentamidine—Renal failure—Methotrexate—lung cancer	6.79e-05	0.00039	CcSEcCtD
Pentamidine—Rash—Vinorelbine—lung cancer	6.76e-05	0.000388	CcSEcCtD
Pentamidine—Dermatitis—Vinorelbine—lung cancer	6.75e-05	0.000388	CcSEcCtD
Pentamidine—Hypotension—Paclitaxel—lung cancer	6.73e-05	0.000387	CcSEcCtD
Pentamidine—Stomatitis—Methotrexate—lung cancer	6.73e-05	0.000387	CcSEcCtD
Pentamidine—Headache—Vinorelbine—lung cancer	6.71e-05	0.000386	CcSEcCtD
Pentamidine—Syncope—Docetaxel—lung cancer	6.71e-05	0.000386	CcSEcCtD
Pentamidine—Conjunctivitis—Methotrexate—lung cancer	6.71e-05	0.000385	CcSEcCtD
Pentamidine—Asthma—Doxorubicin—lung cancer	6.7e-05	0.000385	CcSEcCtD
Pentamidine—Influenza—Doxorubicin—lung cancer	6.7e-05	0.000385	CcSEcCtD
Pentamidine—Leukopenia—Docetaxel—lung cancer	6.7e-05	0.000385	CcSEcCtD
Pentamidine—Eosinophilia—Doxorubicin—lung cancer	6.64e-05	0.000381	CcSEcCtD
Pentamidine—Palpitations—Docetaxel—lung cancer	6.61e-05	0.00038	CcSEcCtD
Pentamidine—Feeling abnormal—Cisplatin—lung cancer	6.61e-05	0.00038	CcSEcCtD
Pentamidine—Paraesthesia—Etoposide—lung cancer	6.6e-05	0.000379	CcSEcCtD
Pentamidine—Haematuria—Methotrexate—lung cancer	6.58e-05	0.000378	CcSEcCtD
Pentamidine—Loss of consciousness—Docetaxel—lung cancer	6.58e-05	0.000378	CcSEcCtD
Pentamidine—Pancreatitis—Doxorubicin—lung cancer	6.57e-05	0.000378	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Paclitaxel—lung cancer	6.57e-05	0.000377	CcSEcCtD
Pentamidine—Dyspnoea—Etoposide—lung cancer	6.55e-05	0.000376	CcSEcCtD
Pentamidine—Somnolence—Etoposide—lung cancer	6.53e-05	0.000375	CcSEcCtD
Pentamidine—Cough—Docetaxel—lung cancer	6.53e-05	0.000375	CcSEcCtD
Pentamidine—Insomnia—Paclitaxel—lung cancer	6.52e-05	0.000374	CcSEcCtD
Pentamidine—Hypersensitivity—Irinotecan—lung cancer	6.51e-05	0.000374	CcSEcCtD
Pentamidine—Convulsion—Docetaxel—lung cancer	6.49e-05	0.000373	CcSEcCtD
Pentamidine—Paraesthesia—Paclitaxel—lung cancer	6.47e-05	0.000372	CcSEcCtD
Pentamidine—Hypertension—Docetaxel—lung cancer	6.46e-05	0.000371	CcSEcCtD
Pentamidine—Bronchitis—Doxorubicin—lung cancer	6.45e-05	0.00037	CcSEcCtD
Pentamidine—Dyspnoea—Paclitaxel—lung cancer	6.43e-05	0.000369	CcSEcCtD
Pentamidine—Somnolence—Paclitaxel—lung cancer	6.41e-05	0.000368	CcSEcCtD
Pentamidine—Decreased appetite—Etoposide—lung cancer	6.39e-05	0.000367	CcSEcCtD
Pentamidine—Arthralgia—Docetaxel—lung cancer	6.37e-05	0.000366	CcSEcCtD
Pentamidine—Chest pain—Docetaxel—lung cancer	6.37e-05	0.000366	CcSEcCtD
Pentamidine—Myalgia—Docetaxel—lung cancer	6.37e-05	0.000366	CcSEcCtD
Pentamidine—Pancytopenia—Doxorubicin—lung cancer	6.37e-05	0.000366	CcSEcCtD
Pentamidine—Nausea—Vinorelbine—lung cancer	6.36e-05	0.000366	CcSEcCtD
Pentamidine—Dyspepsia—Paclitaxel—lung cancer	6.34e-05	0.000364	CcSEcCtD
Pentamidine—Body temperature increased—Cisplatin—lung cancer	6.34e-05	0.000364	CcSEcCtD
Pentamidine—Asthenia—Irinotecan—lung cancer	6.34e-05	0.000364	CcSEcCtD
Pentamidine—Fatigue—Etoposide—lung cancer	6.34e-05	0.000364	CcSEcCtD
Pentamidine—Pain—Etoposide—lung cancer	6.29e-05	0.000361	CcSEcCtD
Pentamidine—Constipation—Etoposide—lung cancer	6.29e-05	0.000361	CcSEcCtD
Pentamidine—Neutropenia—Doxorubicin—lung cancer	6.27e-05	0.00036	CcSEcCtD
Pentamidine—Decreased appetite—Paclitaxel—lung cancer	6.27e-05	0.00036	CcSEcCtD
Pentamidine—Dry mouth—Docetaxel—lung cancer	6.23e-05	0.000358	CcSEcCtD
Pentamidine—Fatigue—Paclitaxel—lung cancer	6.21e-05	0.000357	CcSEcCtD
Pentamidine—Hepatitis—Methotrexate—lung cancer	6.2e-05	0.000356	CcSEcCtD
Pentamidine—Asthenia—Gemcitabine—lung cancer	6.18e-05	0.000355	CcSEcCtD
Pentamidine—Pain—Paclitaxel—lung cancer	6.16e-05	0.000354	CcSEcCtD
Pentamidine—Constipation—Paclitaxel—lung cancer	6.16e-05	0.000354	CcSEcCtD
Pentamidine—Confusional state—Docetaxel—lung cancer	6.16e-05	0.000354	CcSEcCtD
Pentamidine—Pharyngitis—Methotrexate—lung cancer	6.15e-05	0.000353	CcSEcCtD
Pentamidine—Anaphylactic shock—Docetaxel—lung cancer	6.11e-05	0.000351	CcSEcCtD
Pentamidine—Pruritus—Gemcitabine—lung cancer	6.09e-05	0.00035	CcSEcCtD
Pentamidine—Infection—Docetaxel—lung cancer	6.07e-05	0.000349	CcSEcCtD
Pentamidine—Feeling abnormal—Etoposide—lung cancer	6.06e-05	0.000348	CcSEcCtD
Pentamidine—Hyperglycaemia—Doxorubicin—lung cancer	6.05e-05	0.000347	CcSEcCtD
Pentamidine—Diarrhoea—Irinotecan—lung cancer	6.05e-05	0.000347	CcSEcCtD
Pentamidine—Gastrointestinal pain—Etoposide—lung cancer	6.01e-05	0.000345	CcSEcCtD
Pentamidine—Shock—Docetaxel—lung cancer	6.01e-05	0.000345	CcSEcCtD
Pentamidine—Thrombocytopenia—Docetaxel—lung cancer	5.98e-05	0.000344	CcSEcCtD
Pentamidine—Drowsiness—Doxorubicin—lung cancer	5.98e-05	0.000343	CcSEcCtD
Pentamidine—Tachycardia—Docetaxel—lung cancer	5.96e-05	0.000342	CcSEcCtD
Pentamidine—Feeling abnormal—Paclitaxel—lung cancer	5.94e-05	0.000341	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	5.93e-05	0.00034	CcSEcCtD
Pentamidine—Hypersensitivity—Cisplatin—lung cancer	5.91e-05	0.00034	CcSEcCtD
Pentamidine—Gastrointestinal pain—Paclitaxel—lung cancer	5.89e-05	0.000339	CcSEcCtD
Pentamidine—Diarrhoea—Gemcitabine—lung cancer	5.89e-05	0.000338	CcSEcCtD
Pentamidine—Renal failure—Doxorubicin—lung cancer	5.88e-05	0.000338	CcSEcCtD
Pentamidine—Erythema multiforme—Methotrexate—lung cancer	5.86e-05	0.000337	CcSEcCtD
Pentamidine—Neuropathy peripheral—Doxorubicin—lung cancer	5.86e-05	0.000337	CcSEcCtD
Pentamidine—Dizziness—Irinotecan—lung cancer	5.84e-05	0.000336	CcSEcCtD
Pentamidine—Urticaria—Etoposide—lung cancer	5.84e-05	0.000335	CcSEcCtD
Pentamidine—Stomatitis—Doxorubicin—lung cancer	5.83e-05	0.000335	CcSEcCtD
Pentamidine—Anorexia—Docetaxel—lung cancer	5.82e-05	0.000335	CcSEcCtD
Pentamidine—Body temperature increased—Etoposide—lung cancer	5.81e-05	0.000334	CcSEcCtD
Pentamidine—Abdominal pain—Etoposide—lung cancer	5.81e-05	0.000334	CcSEcCtD
Pentamidine—Conjunctivitis—Doxorubicin—lung cancer	5.81e-05	0.000334	CcSEcCtD
Pentamidine—Asthenia—Cisplatin—lung cancer	5.76e-05	0.000331	CcSEcCtD
Pentamidine—Urticaria—Paclitaxel—lung cancer	5.73e-05	0.000329	CcSEcCtD
Pentamidine—Hypotension—Docetaxel—lung cancer	5.71e-05	0.000328	CcSEcCtD
Pentamidine—Haematuria—Doxorubicin—lung cancer	5.7e-05	0.000327	CcSEcCtD
Pentamidine—Abdominal pain—Paclitaxel—lung cancer	5.7e-05	0.000327	CcSEcCtD
Pentamidine—Body temperature increased—Paclitaxel—lung cancer	5.7e-05	0.000327	CcSEcCtD
Pentamidine—Vomiting—Irinotecan—lung cancer	5.62e-05	0.000323	CcSEcCtD
Pentamidine—Sinusitis—Doxorubicin—lung cancer	5.61e-05	0.000322	CcSEcCtD
Pentamidine—Rash—Irinotecan—lung cancer	5.57e-05	0.00032	CcSEcCtD
Pentamidine—Dermatitis—Irinotecan—lung cancer	5.57e-05	0.00032	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Docetaxel—lung cancer	5.57e-05	0.00032	CcSEcCtD
Pentamidine—Chills—Methotrexate—lung cancer	5.56e-05	0.000319	CcSEcCtD
Pentamidine—Headache—Irinotecan—lung cancer	5.54e-05	0.000318	CcSEcCtD
Pentamidine—Insomnia—Docetaxel—lung cancer	5.53e-05	0.000317	CcSEcCtD
Pentamidine—Diarrhoea—Cisplatin—lung cancer	5.49e-05	0.000315	CcSEcCtD
Pentamidine—Paraesthesia—Docetaxel—lung cancer	5.49e-05	0.000315	CcSEcCtD
Pentamidine—Vomiting—Gemcitabine—lung cancer	5.47e-05	0.000314	CcSEcCtD
Pentamidine—Bradycardia—Doxorubicin—lung cancer	5.46e-05	0.000314	CcSEcCtD
Pentamidine—Dyspnoea—Docetaxel—lung cancer	5.45e-05	0.000313	CcSEcCtD
Pentamidine—Somnolence—Docetaxel—lung cancer	5.43e-05	0.000312	CcSEcCtD
Pentamidine—Rash—Gemcitabine—lung cancer	5.43e-05	0.000312	CcSEcCtD
Pentamidine—Dermatitis—Gemcitabine—lung cancer	5.42e-05	0.000312	CcSEcCtD
Pentamidine—Hypersensitivity—Etoposide—lung cancer	5.42e-05	0.000311	CcSEcCtD
Pentamidine—Erythema—Methotrexate—lung cancer	5.39e-05	0.00031	CcSEcCtD
Pentamidine—Headache—Gemcitabine—lung cancer	5.39e-05	0.00031	CcSEcCtD
Pentamidine—Rhinitis—Doxorubicin—lung cancer	5.38e-05	0.000309	CcSEcCtD
Pentamidine—Dyspepsia—Docetaxel—lung cancer	5.38e-05	0.000309	CcSEcCtD
Pentamidine—Hepatitis—Doxorubicin—lung cancer	5.37e-05	0.000308	CcSEcCtD
Pentamidine—Hypoaesthesia—Doxorubicin—lung cancer	5.34e-05	0.000307	CcSEcCtD
Pentamidine—Pharyngitis—Doxorubicin—lung cancer	5.33e-05	0.000306	CcSEcCtD
Pentamidine—Decreased appetite—Docetaxel—lung cancer	5.31e-05	0.000305	CcSEcCtD
Pentamidine—Hypersensitivity—Paclitaxel—lung cancer	5.31e-05	0.000305	CcSEcCtD
Pentamidine—Oedema peripheral—Doxorubicin—lung cancer	5.29e-05	0.000304	CcSEcCtD
Pentamidine—Dysgeusia—Methotrexate—lung cancer	5.28e-05	0.000303	CcSEcCtD
Pentamidine—Asthenia—Etoposide—lung cancer	5.27e-05	0.000303	CcSEcCtD
Pentamidine—Fatigue—Docetaxel—lung cancer	5.27e-05	0.000303	CcSEcCtD
Pentamidine—Nausea—Irinotecan—lung cancer	5.25e-05	0.000302	CcSEcCtD
Pentamidine—Pain—Docetaxel—lung cancer	5.22e-05	0.0003	CcSEcCtD
Pentamidine—Constipation—Docetaxel—lung cancer	5.22e-05	0.0003	CcSEcCtD
Pentamidine—Pruritus—Etoposide—lung cancer	5.2e-05	0.000299	CcSEcCtD
Pentamidine—Asthenia—Paclitaxel—lung cancer	5.17e-05	0.000297	CcSEcCtD
Pentamidine—Nausea—Gemcitabine—lung cancer	5.11e-05	0.000294	CcSEcCtD
Pentamidine—Vomiting—Cisplatin—lung cancer	5.1e-05	0.000293	CcSEcCtD
Pentamidine—Pruritus—Paclitaxel—lung cancer	5.1e-05	0.000293	CcSEcCtD
Pentamidine—Vision blurred—Methotrexate—lung cancer	5.08e-05	0.000292	CcSEcCtD
Pentamidine—Erythema multiforme—Doxorubicin—lung cancer	5.07e-05	0.000291	CcSEcCtD
Pentamidine—Rash—Cisplatin—lung cancer	5.06e-05	0.000291	CcSEcCtD
Pentamidine—Dermatitis—Cisplatin—lung cancer	5.05e-05	0.00029	CcSEcCtD
Pentamidine—Feeling abnormal—Docetaxel—lung cancer	5.03e-05	0.000289	CcSEcCtD
Pentamidine—Diarrhoea—Etoposide—lung cancer	5.03e-05	0.000289	CcSEcCtD
Pentamidine—Gastrointestinal pain—Docetaxel—lung cancer	5e-05	0.000287	CcSEcCtD
Pentamidine—Anaemia—Methotrexate—lung cancer	4.99e-05	0.000286	CcSEcCtD
Pentamidine—Flushing—Doxorubicin—lung cancer	4.98e-05	0.000286	CcSEcCtD
Pentamidine—Diarrhoea—Paclitaxel—lung cancer	4.93e-05	0.000283	CcSEcCtD
Pentamidine—Dizziness—Etoposide—lung cancer	4.86e-05	0.000279	CcSEcCtD
Pentamidine—Vertigo—Methotrexate—lung cancer	4.85e-05	0.000278	CcSEcCtD
Pentamidine—Abdominal pain—Docetaxel—lung cancer	4.83e-05	0.000277	CcSEcCtD
Pentamidine—Body temperature increased—Docetaxel—lung cancer	4.83e-05	0.000277	CcSEcCtD
Pentamidine—Leukopenia—Methotrexate—lung cancer	4.83e-05	0.000277	CcSEcCtD
Pentamidine—Chills—Doxorubicin—lung cancer	4.82e-05	0.000277	CcSEcCtD
Pentamidine—Arrhythmia—Doxorubicin—lung cancer	4.79e-05	0.000275	CcSEcCtD
Pentamidine—Dizziness—Paclitaxel—lung cancer	4.77e-05	0.000274	CcSEcCtD
Pentamidine—Nausea—Cisplatin—lung cancer	4.77e-05	0.000274	CcSEcCtD
Pentamidine—Cough—Methotrexate—lung cancer	4.71e-05	0.00027	CcSEcCtD
Pentamidine—Convulsion—Methotrexate—lung cancer	4.67e-05	0.000269	CcSEcCtD
Pentamidine—Vomiting—Etoposide—lung cancer	4.67e-05	0.000268	CcSEcCtD
Pentamidine—Erythema—Doxorubicin—lung cancer	4.67e-05	0.000268	CcSEcCtD
Pentamidine—Rash—Etoposide—lung cancer	4.63e-05	0.000266	CcSEcCtD
Pentamidine—Dermatitis—Etoposide—lung cancer	4.63e-05	0.000266	CcSEcCtD
Pentamidine—Headache—Etoposide—lung cancer	4.6e-05	0.000265	CcSEcCtD
Pentamidine—Arthralgia—Methotrexate—lung cancer	4.59e-05	0.000264	CcSEcCtD
Pentamidine—Chest pain—Methotrexate—lung cancer	4.59e-05	0.000264	CcSEcCtD
Pentamidine—Myalgia—Methotrexate—lung cancer	4.59e-05	0.000264	CcSEcCtD
Pentamidine—Tension—Doxorubicin—lung cancer	4.58e-05	0.000263	CcSEcCtD
Pentamidine—Vomiting—Paclitaxel—lung cancer	4.58e-05	0.000263	CcSEcCtD
Pentamidine—Dysgeusia—Doxorubicin—lung cancer	4.57e-05	0.000263	CcSEcCtD
Pentamidine—Rash—Paclitaxel—lung cancer	4.54e-05	0.000261	CcSEcCtD
Pentamidine—Dermatitis—Paclitaxel—lung cancer	4.54e-05	0.000261	CcSEcCtD
Pentamidine—Discomfort—Methotrexate—lung cancer	4.54e-05	0.000261	CcSEcCtD
Pentamidine—Nervousness—Doxorubicin—lung cancer	4.54e-05	0.000261	CcSEcCtD
Pentamidine—Headache—Paclitaxel—lung cancer	4.52e-05	0.000259	CcSEcCtD
Pentamidine—Hypersensitivity—Docetaxel—lung cancer	4.5e-05	0.000259	CcSEcCtD
Pentamidine—Confusional state—Methotrexate—lung cancer	4.44e-05	0.000255	CcSEcCtD
Pentamidine—Anaphylactic shock—Methotrexate—lung cancer	4.4e-05	0.000253	CcSEcCtD
Pentamidine—Vision blurred—Doxorubicin—lung cancer	4.4e-05	0.000253	CcSEcCtD
Pentamidine—Asthenia—Docetaxel—lung cancer	4.38e-05	0.000252	CcSEcCtD
Pentamidine—Infection—Methotrexate—lung cancer	4.37e-05	0.000251	CcSEcCtD
Pentamidine—Nausea—Etoposide—lung cancer	4.37e-05	0.000251	CcSEcCtD
Pentamidine—Pruritus—Docetaxel—lung cancer	4.32e-05	0.000248	CcSEcCtD
Pentamidine—Anaemia—Doxorubicin—lung cancer	4.32e-05	0.000248	CcSEcCtD
Pentamidine—Thrombocytopenia—Methotrexate—lung cancer	4.31e-05	0.000248	CcSEcCtD
Pentamidine—Nausea—Paclitaxel—lung cancer	4.28e-05	0.000246	CcSEcCtD
Pentamidine—Vertigo—Doxorubicin—lung cancer	4.2e-05	0.000241	CcSEcCtD
Pentamidine—Anorexia—Methotrexate—lung cancer	4.2e-05	0.000241	CcSEcCtD
Pentamidine—Syncope—Doxorubicin—lung cancer	4.19e-05	0.000241	CcSEcCtD
Pentamidine—Leukopenia—Doxorubicin—lung cancer	4.18e-05	0.00024	CcSEcCtD
Pentamidine—Diarrhoea—Docetaxel—lung cancer	4.18e-05	0.00024	CcSEcCtD
Pentamidine—Palpitations—Doxorubicin—lung cancer	4.13e-05	0.000237	CcSEcCtD
Pentamidine—Hypotension—Methotrexate—lung cancer	4.11e-05	0.000236	CcSEcCtD
Pentamidine—Loss of consciousness—Doxorubicin—lung cancer	4.11e-05	0.000236	CcSEcCtD
Pentamidine—Cough—Doxorubicin—lung cancer	4.08e-05	0.000234	CcSEcCtD
Pentamidine—Convulsion—Doxorubicin—lung cancer	4.05e-05	0.000233	CcSEcCtD
Pentamidine—Dizziness—Docetaxel—lung cancer	4.04e-05	0.000232	CcSEcCtD
Pentamidine—Hypertension—Doxorubicin—lung cancer	4.03e-05	0.000232	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Methotrexate—lung cancer	4.01e-05	0.00023	CcSEcCtD
Pentamidine—Insomnia—Methotrexate—lung cancer	3.98e-05	0.000229	CcSEcCtD
Pentamidine—Myalgia—Doxorubicin—lung cancer	3.98e-05	0.000228	CcSEcCtD
Pentamidine—Arthralgia—Doxorubicin—lung cancer	3.98e-05	0.000228	CcSEcCtD
Pentamidine—Chest pain—Doxorubicin—lung cancer	3.98e-05	0.000228	CcSEcCtD
Pentamidine—Anxiety—Doxorubicin—lung cancer	3.96e-05	0.000228	CcSEcCtD
Pentamidine—Paraesthesia—Methotrexate—lung cancer	3.95e-05	0.000227	CcSEcCtD
Pentamidine—Discomfort—Doxorubicin—lung cancer	3.93e-05	0.000226	CcSEcCtD
Pentamidine—Dyspnoea—Methotrexate—lung cancer	3.93e-05	0.000225	CcSEcCtD
Pentamidine—Somnolence—Methotrexate—lung cancer	3.91e-05	0.000225	CcSEcCtD
Pentamidine—Dry mouth—Doxorubicin—lung cancer	3.89e-05	0.000223	CcSEcCtD
Pentamidine—Vomiting—Docetaxel—lung cancer	3.88e-05	0.000223	CcSEcCtD
Pentamidine—Dyspepsia—Methotrexate—lung cancer	3.88e-05	0.000223	CcSEcCtD
Pentamidine—Rash—Docetaxel—lung cancer	3.85e-05	0.000221	CcSEcCtD
Pentamidine—Dermatitis—Docetaxel—lung cancer	3.85e-05	0.000221	CcSEcCtD
Pentamidine—Confusional state—Doxorubicin—lung cancer	3.84e-05	0.000221	CcSEcCtD
Pentamidine—Decreased appetite—Methotrexate—lung cancer	3.83e-05	0.00022	CcSEcCtD
Pentamidine—Headache—Docetaxel—lung cancer	3.83e-05	0.00022	CcSEcCtD
Pentamidine—Anaphylactic shock—Doxorubicin—lung cancer	3.81e-05	0.000219	CcSEcCtD
Pentamidine—Fatigue—Methotrexate—lung cancer	3.8e-05	0.000218	CcSEcCtD
Pentamidine—Infection—Doxorubicin—lung cancer	3.79e-05	0.000218	CcSEcCtD
Pentamidine—Pain—Methotrexate—lung cancer	3.77e-05	0.000216	CcSEcCtD
Pentamidine—Shock—Doxorubicin—lung cancer	3.75e-05	0.000215	CcSEcCtD
Pentamidine—Thrombocytopenia—Doxorubicin—lung cancer	3.73e-05	0.000214	CcSEcCtD
Pentamidine—Tachycardia—Doxorubicin—lung cancer	3.72e-05	0.000214	CcSEcCtD
Pentamidine—Anorexia—Doxorubicin—lung cancer	3.63e-05	0.000209	CcSEcCtD
Pentamidine—Nausea—Docetaxel—lung cancer	3.63e-05	0.000208	CcSEcCtD
Pentamidine—Feeling abnormal—Methotrexate—lung cancer	3.63e-05	0.000208	CcSEcCtD
Pentamidine—Gastrointestinal pain—Methotrexate—lung cancer	3.6e-05	0.000207	CcSEcCtD
Pentamidine—Hypotension—Doxorubicin—lung cancer	3.56e-05	0.000205	CcSEcCtD
Pentamidine—Urticaria—Methotrexate—lung cancer	3.5e-05	0.000201	CcSEcCtD
Pentamidine—Abdominal pain—Methotrexate—lung cancer	3.48e-05	0.0002	CcSEcCtD
Pentamidine—Body temperature increased—Methotrexate—lung cancer	3.48e-05	0.0002	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.47e-05	0.0002	CcSEcCtD
Pentamidine—Insomnia—Doxorubicin—lung cancer	3.45e-05	0.000198	CcSEcCtD
Pentamidine—Paraesthesia—Doxorubicin—lung cancer	3.42e-05	0.000197	CcSEcCtD
Pentamidine—Dyspnoea—Doxorubicin—lung cancer	3.4e-05	0.000195	CcSEcCtD
Pentamidine—Somnolence—Doxorubicin—lung cancer	3.39e-05	0.000195	CcSEcCtD
Pentamidine—Dyspepsia—Doxorubicin—lung cancer	3.36e-05	0.000193	CcSEcCtD
Pentamidine—Decreased appetite—Doxorubicin—lung cancer	3.31e-05	0.00019	CcSEcCtD
Pentamidine—Fatigue—Doxorubicin—lung cancer	3.29e-05	0.000189	CcSEcCtD
Pentamidine—Constipation—Doxorubicin—lung cancer	3.26e-05	0.000187	CcSEcCtD
Pentamidine—Pain—Doxorubicin—lung cancer	3.26e-05	0.000187	CcSEcCtD
Pentamidine—Hypersensitivity—Methotrexate—lung cancer	3.24e-05	0.000186	CcSEcCtD
Pentamidine—Asthenia—Methotrexate—lung cancer	3.16e-05	0.000181	CcSEcCtD
Pentamidine—Feeling abnormal—Doxorubicin—lung cancer	3.14e-05	0.00018	CcSEcCtD
Pentamidine—Gastrointestinal pain—Doxorubicin—lung cancer	3.12e-05	0.000179	CcSEcCtD
Pentamidine—Pruritus—Methotrexate—lung cancer	3.12e-05	0.000179	CcSEcCtD
Pentamidine—Urticaria—Doxorubicin—lung cancer	3.03e-05	0.000174	CcSEcCtD
Pentamidine—Abdominal pain—Doxorubicin—lung cancer	3.01e-05	0.000173	CcSEcCtD
Pentamidine—Body temperature increased—Doxorubicin—lung cancer	3.01e-05	0.000173	CcSEcCtD
Pentamidine—Diarrhoea—Methotrexate—lung cancer	3.01e-05	0.000173	CcSEcCtD
Pentamidine—Dizziness—Methotrexate—lung cancer	2.91e-05	0.000167	CcSEcCtD
Pentamidine—Hypersensitivity—Doxorubicin—lung cancer	2.81e-05	0.000161	CcSEcCtD
Pentamidine—Vomiting—Methotrexate—lung cancer	2.8e-05	0.000161	CcSEcCtD
Pentamidine—Rash—Methotrexate—lung cancer	2.78e-05	0.000159	CcSEcCtD
Pentamidine—Dermatitis—Methotrexate—lung cancer	2.77e-05	0.000159	CcSEcCtD
Pentamidine—Headache—Methotrexate—lung cancer	2.76e-05	0.000158	CcSEcCtD
Pentamidine—Asthenia—Doxorubicin—lung cancer	2.74e-05	0.000157	CcSEcCtD
Pentamidine—Pruritus—Doxorubicin—lung cancer	2.7e-05	0.000155	CcSEcCtD
Pentamidine—Nausea—Methotrexate—lung cancer	2.62e-05	0.00015	CcSEcCtD
Pentamidine—Diarrhoea—Doxorubicin—lung cancer	2.61e-05	0.00015	CcSEcCtD
Pentamidine—Dizziness—Doxorubicin—lung cancer	2.52e-05	0.000145	CcSEcCtD
Pentamidine—Vomiting—Doxorubicin—lung cancer	2.42e-05	0.000139	CcSEcCtD
Pentamidine—Rash—Doxorubicin—lung cancer	2.4e-05	0.000138	CcSEcCtD
Pentamidine—Dermatitis—Doxorubicin—lung cancer	2.4e-05	0.000138	CcSEcCtD
Pentamidine—Headache—Doxorubicin—lung cancer	2.39e-05	0.000137	CcSEcCtD
Pentamidine—Nausea—Doxorubicin—lung cancer	2.26e-05	0.00013	CcSEcCtD
Pentamidine—CYP2C8—Metabolism—ENO1—lung cancer	6.41e-06	5.58e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.39e-06	5.56e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.31e-06	5.49e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ENO2—lung cancer	6.3e-06	5.48e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—HPGDS—lung cancer	6.3e-06	5.48e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP2E1—lung cancer	6.27e-06	5.46e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PPP2R1B—lung cancer	6.26e-06	5.45e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CA—lung cancer	6.25e-06	5.44e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ALDOA—lung cancer	6.25e-06	5.44e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP2A7—lung cancer	6.25e-06	5.44e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTA1—lung cancer	6.21e-06	5.4e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—NQO1—lung cancer	6.2e-06	5.4e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.17e-06	5.37e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ABCC3—lung cancer	6.14e-06	5.34e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SDC4—lung cancer	6.12e-06	5.32e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTT1—lung cancer	6.11e-06	5.32e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.07e-06	5.29e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NCOA3—lung cancer	6.07e-06	5.28e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TP53—lung cancer	6.05e-06	5.27e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GCLC—lung cancer	6.04e-06	5.25e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP2A6—lung cancer	6.04e-06	5.25e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.02e-06	5.24e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.01e-06	5.23e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AKR1C1—lung cancer	5.94e-06	5.17e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—STK11—lung cancer	5.92e-06	5.15e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ADCY1—lung cancer	5.91e-06	5.14e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ABCG2—lung cancer	5.91e-06	5.14e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTEN—lung cancer	5.89e-06	5.13e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ENO2—lung cancer	5.79e-06	5.04e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—HPGDS—lung cancer	5.79e-06	5.04e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—HRAS—lung cancer	5.79e-06	5.04e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—UGT1A1—lung cancer	5.77e-06	5.02e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PPP2R1B—lung cancer	5.76e-06	5.01e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP2E1—lung cancer	5.75e-06	5.01e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ENO1—lung cancer	5.72e-06	4.98e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.7e-06	4.96e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—NQO1—lung cancer	5.69e-06	4.95e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.63e-06	4.9e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTT1—lung cancer	5.62e-06	4.89e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—EP300—lung cancer	5.62e-06	4.89e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—STK11—lung cancer	5.59e-06	4.87e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—RRM1—lung cancer	5.57e-06	4.85e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTA3—lung cancer	5.57e-06	4.85e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.57e-06	4.85e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GNG11—lung cancer	5.56e-06	4.84e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP2A6—lung cancer	5.55e-06	4.83e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GCLC—lung cancer	5.55e-06	4.83e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL6—lung cancer	5.54e-06	4.82e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	5.54e-06	4.82e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.52e-06	4.8e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTP1—lung cancer	5.48e-06	4.77e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CAT—lung cancer	5.33e-06	4.64e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ALDOA—lung cancer	5.3e-06	4.61e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ENO1—lung cancer	5.26e-06	4.58e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.25e-06	4.57e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—B4GALT5—lung cancer	5.24e-06	4.56e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ABCB1—lung cancer	5.18e-06	4.51e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTP1—lung cancer	5.17e-06	4.5e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NCOA3—lung cancer	5.14e-06	4.48e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP2E1—lung cancer	5.13e-06	4.47e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—STK11—lung cancer	5.13e-06	4.46e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—AKT1—lung cancer	5.11e-06	4.45e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTA4—lung cancer	5.1e-06	4.43e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—TYMS—lung cancer	5.09e-06	4.43e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NQO1—lung cancer	5.08e-06	4.42e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	5.05e-06	4.4e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CAT—lung cancer	5.03e-06	4.38e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTM1—lung cancer	5.03e-06	4.38e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.01e-06	4.36e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ADCY1—lung cancer	5e-06	4.35e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ABCG2—lung cancer	5e-06	4.35e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.97e-06	4.33e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTA2—lung cancer	4.97e-06	4.32e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.93e-06	4.29e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—HPGDS—lung cancer	4.91e-06	4.27e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ENO2—lung cancer	4.91e-06	4.27e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ABCB1—lung cancer	4.9e-06	4.26e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PPP2R1B—lung cancer	4.88e-06	4.24e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.81e-06	4.19e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.81e-06	4.19e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—TYMS—lung cancer	4.81e-06	4.19e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTA1—lung cancer	4.79e-06	4.17e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP1A1—lung cancer	4.77e-06	4.15e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTT1—lung cancer	4.76e-06	4.14e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTM1—lung cancer	4.75e-06	4.14e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTP1—lung cancer	4.74e-06	4.13e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ABCC3—lung cancer	4.74e-06	4.12e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ERCC2—lung cancer	4.73e-06	4.12e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP2E1—lung cancer	4.72e-06	4.11e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GCLC—lung cancer	4.7e-06	4.09e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP2A6—lung cancer	4.7e-06	4.09e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.69e-06	4.08e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NQO1—lung cancer	4.67e-06	4.06e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CAT—lung cancer	4.62e-06	4.02e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.59e-06	3.99e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AKR1C1—lung cancer	4.59e-06	3.99e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—STK11—lung cancer	4.58e-06	3.98e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ABCB1—lung cancer	4.49e-06	3.91e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ERCC2—lung cancer	4.47e-06	3.89e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ENO1—lung cancer	4.46e-06	3.88e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—UGT1A1—lung cancer	4.45e-06	3.88e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.44e-06	3.87e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—TYMS—lung cancer	4.41e-06	3.84e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.39e-06	3.82e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTM1—lung cancer	4.36e-06	3.79e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.3e-06	3.74e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GNG11—lung cancer	4.29e-06	3.74e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTP1—lung cancer	4.23e-06	3.68e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—STK11—lung cancer	4.21e-06	3.66e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CA—lung cancer	4.16e-06	3.62e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP1A1—lung cancer	4.13e-06	3.6e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CAT—lung cancer	4.12e-06	3.59e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ERCC2—lung cancer	4.1e-06	3.57e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.1e-06	3.57e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—APOA1—lung cancer	4.09e-06	3.56e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALDOA—lung cancer	4.09e-06	3.56e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ABCB1—lung cancer	4.01e-06	3.49e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP2E1—lung cancer	4e-06	3.48e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NCOA3—lung cancer	3.97e-06	3.45e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NQO1—lung cancer	3.96e-06	3.44e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—TYMS—lung cancer	3.94e-06	3.43e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTP1—lung cancer	3.89e-06	3.39e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTM1—lung cancer	3.89e-06	3.39e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.87e-06	3.37e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—APOA1—lung cancer	3.87e-06	3.37e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ABCG2—lung cancer	3.86e-06	3.36e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ADCY1—lung cancer	3.86e-06	3.36e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.84e-06	3.34e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CAT—lung cancer	3.79e-06	3.3e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ENO2—lung cancer	3.79e-06	3.3e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HPGDS—lung cancer	3.79e-06	3.3e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.76e-06	3.28e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CG—lung cancer	3.74e-06	3.25e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.7e-06	3.22e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP1A1—lung cancer	3.69e-06	3.21e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ABCB1—lung cancer	3.69e-06	3.21e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTT1—lung cancer	3.67e-06	3.2e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ERCC2—lung cancer	3.66e-06	3.18e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GCLC—lung cancer	3.63e-06	3.16e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP2A6—lung cancer	3.63e-06	3.16e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—TYMS—lung cancer	3.62e-06	3.15e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTM1—lung cancer	3.58e-06	3.11e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—STK11—lung cancer	3.57e-06	3.1e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—POMC—lung cancer	3.56e-06	3.1e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—APOA1—lung cancer	3.55e-06	3.09e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CG—lung cancer	3.53e-06	3.07e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CREBBP—lung cancer	3.46e-06	3.02e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ENO1—lung cancer	3.44e-06	3e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.39e-06	2.95e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—AKT1—lung cancer	3.39e-06	2.95e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP1A1—lung cancer	3.39e-06	2.95e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ERCC2—lung cancer	3.36e-06	2.93e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—POMC—lung cancer	3.36e-06	2.92e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.35e-06	2.91e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTP1—lung cancer	3.3e-06	2.87e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CD—lung cancer	3.29e-06	2.86e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CREBBP—lung cancer	3.27e-06	2.85e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ALB—lung cancer	3.24e-06	2.82e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CG—lung cancer	3.24e-06	2.82e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CAT—lung cancer	3.21e-06	2.79e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.19e-06	2.78e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—APOA1—lung cancer	3.16e-06	2.75e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ABCB1—lung cancer	3.12e-06	2.72e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CD—lung cancer	3.1e-06	2.7e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP2E1—lung cancer	3.09e-06	2.69e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—POMC—lung cancer	3.08e-06	2.68e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—TYMS—lung cancer	3.07e-06	2.67e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ALB—lung cancer	3.06e-06	2.67e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NQO1—lung cancer	3.05e-06	2.66e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTM1—lung cancer	3.03e-06	2.64e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.03e-06	2.64e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CREBBP—lung cancer	3e-06	2.61e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—APOA1—lung cancer	2.91e-06	2.53e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CG—lung cancer	2.89e-06	2.51e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP1A1—lung cancer	2.87e-06	2.5e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CB—lung cancer	2.86e-06	2.49e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ERCC2—lung cancer	2.85e-06	2.48e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CD—lung cancer	2.85e-06	2.48e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTGS2—lung cancer	2.84e-06	2.47e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ALB—lung cancer	2.81e-06	2.44e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—STK11—lung cancer	2.75e-06	2.39e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—POMC—lung cancer	2.75e-06	2.39e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CB—lung cancer	2.71e-06	2.35e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTGS2—lung cancer	2.68e-06	2.33e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CREBBP—lung cancer	2.68e-06	2.33e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CG—lung cancer	2.66e-06	2.31e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTP1—lung cancer	2.55e-06	2.22e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CD—lung cancer	2.54e-06	2.21e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—POMC—lung cancer	2.53e-06	2.2e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ALB—lung cancer	2.51e-06	2.18e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CB—lung cancer	2.48e-06	2.16e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CAT—lung cancer	2.48e-06	2.16e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTEN—lung cancer	2.47e-06	2.15e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—APOA1—lung cancer	2.47e-06	2.15e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CREBBP—lung cancer	2.46e-06	2.14e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTGS2—lung cancer	2.46e-06	2.14e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ABCB1—lung cancer	2.41e-06	2.1e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—TYMS—lung cancer	2.37e-06	2.06e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.36e-06	2.05e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—EP300—lung cancer	2.36e-06	2.05e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTM1—lung cancer	2.34e-06	2.04e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTEN—lung cancer	2.34e-06	2.03e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CD—lung cancer	2.34e-06	2.03e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ALB—lung cancer	2.31e-06	2.01e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CG—lung cancer	2.25e-06	1.96e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—EP300—lung cancer	2.23e-06	1.94e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP1A1—lung cancer	2.22e-06	1.93e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CB—lung cancer	2.21e-06	1.93e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ERCC2—lung cancer	2.2e-06	1.91e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTGS2—lung cancer	2.19e-06	1.91e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTEN—lung cancer	2.14e-06	1.87e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—POMC—lung cancer	2.14e-06	1.86e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CREBBP—lung cancer	2.09e-06	1.82e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—EP300—lung cancer	2.04e-06	1.78e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CB—lung cancer	2.04e-06	1.77e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTGS2—lung cancer	2.02e-06	1.76e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CD—lung cancer	1.98e-06	1.72e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ALB—lung cancer	1.95e-06	1.7e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTEN—lung cancer	1.91e-06	1.66e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—APOA1—lung cancer	1.9e-06	1.66e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—EP300—lung cancer	1.82e-06	1.59e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTEN—lung cancer	1.76e-06	1.53e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CA—lung cancer	1.75e-06	1.52e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CG—lung cancer	1.74e-06	1.51e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CB—lung cancer	1.72e-06	1.5e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTGS2—lung cancer	1.71e-06	1.49e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—EP300—lung cancer	1.68e-06	1.46e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—POMC—lung cancer	1.65e-06	1.44e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CA—lung cancer	1.65e-06	1.44e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CREBBP—lung cancer	1.61e-06	1.4e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CD—lung cancer	1.53e-06	1.33e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CA—lung cancer	1.51e-06	1.32e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALB—lung cancer	1.51e-06	1.31e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTEN—lung cancer	1.49e-06	1.3e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—AKT1—lung cancer	1.43e-06	1.24e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—EP300—lung cancer	1.42e-06	1.24e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CA—lung cancer	1.35e-06	1.17e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—AKT1—lung cancer	1.35e-06	1.17e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CB—lung cancer	1.33e-06	1.16e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTGS2—lung cancer	1.32e-06	1.15e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CA—lung cancer	1.24e-06	1.08e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—AKT1—lung cancer	1.24e-06	1.07e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTEN—lung cancer	1.15e-06	1e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—AKT1—lung cancer	1.1e-06	9.59e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—EP300—lung cancer	1.1e-06	9.55e-06	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CA—lung cancer	1.05e-06	9.15e-06	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—AKT1—lung cancer	1.01e-06	8.82e-06	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AKT1—lung cancer	8.59e-07	7.48e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CA—lung cancer	8.11e-07	7.06e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AKT1—lung cancer	6.63e-07	5.77e-06	CbGpPWpGaD
